ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting

Tuesday, November 28, 2017 1:30 PM UTC

SEOUL, South Korea, Nov. 28, 2017 -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR technology at the upcoming American Society of Hematology (ASH) Annual Meeting, being held December 9-12 in Atlanta, Georgia.

The poster presentation entitled “CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells” will cover a study that explored a potential solution to tumors evading immune surveillance by deactivating T cells. Researchers strengthened T cell function by deleting Diacylglycerol kinase (DGKs) using CRISPR/Cas9. The study found that the observed biological effects may also yield new strategies for improving the efficacy of T-cell therapy in combination with signal 2 checkpoint inhibitors in clinical applications.

Details of the presentation are below:

Poster:		3182 - CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells
Lead Author:		In-Young Jung, MS
Poster Session:		703: Adoptive Immunotherapy: Poster II
Date:		Sunday, December 10, 2017
Time:		6:00 - 8:00pm CT
Location:		Georgia World Congress Center Building A, Level 1, Hall A2

About ToolGen, Inc.

ToolGen, Inc. is a biotechnology company focused on the development and application of genome editing technologies. It creates and holds intellectual property rights for essential tools and technologies for editing the genetic information in microbial, plant, animal, and human cells. ToolGen’s mission is to translate the potential of its innovative platform technology into transformative products for biomedicine and agriculture. For more information, please visit www.toolgen.com.

Contacts

Company – Seokjoong Kim +82-2-873-8168
Media – Kirsten Thomas (508) 280-6592
Investors – Tram Bui (646) 536-7035

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting

Editor's Picks

Welcome to EconoTimes